Start every visit with a clear picture
History, open items and recent results are organized for review before the encounter. Clinicians walk in knowing what changed since the last visit.
IntelliHealth® gathers what the chart already holds and lays it out for review, so the first minute of a visit goes to the patient instead of the scroll bar.

Each step stays connected to the record, and every summary links back to where it came from.
History, open items and recent results are organized for review before the encounter. Clinicians walk in knowing what changed since the last visit.
Ask why a line appears and IntelliHealth® shows its reasoning against the chart, with the source one tap away. Nothing is asserted without a place to check it.
Orders, notes and follow-up land on the same timeline as everything else, so the next clinician starts where this one finished.
The morning list shows which patients have new results or open items.
The summary stays on one screen while the conversation stays with the patient.
The source note and the lab value sit side by side, ready for the clinician to judge.
Every encounter is on the timeline. Nothing is waiting at home.
Line by line
Scrolling the chart to find what changed since the last visit
What changed is organized for review before the visit begins
Summaries with no way to check where a line came from
Every line links back to the note, result or order behind it
A dose question that means opening three screens
The source note and the lab value sit side by side
Notes, orders and follow-up kept in different places
Orders, notes and follow-up land on one timeline
Licensed clinicians make every decision. IntelliHealth® makes sure they see what they need to see first, and it never prescribes.

Technology partners


NVIDIA, the NVIDIA logo, and NVIDIA Inception are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Twilio and all related logos are trademarks of Twilio Inc. Other names are trademarks of their respective owners. Membership and platform use do not constitute endorsement.